top of page

Welcome to the Wang Lab

Chemical biology | Drug discovery | Medicinal Chemistry

Current and past research funding sources

NIH logo.png
NIGMS.jpg
NIAID.jpeg
Keck logo.png
UChicago-logo.jpg
KU logo.png
CJD.png
BioNexus logo.png

The Wang lab is focused on designing new drug-like molecules for the treatment of diseases and novel methods or platforms for drug discovery and mechanistic studies in biology. We have two major research directions:

  • New molecules and mechanisms that control RNA splicing

  • Chimeric molecules that recruit new functions on RNAs

Latest news

February 5, 2026

We are excited to share that our project, “Identification of Novel Targets for Enhancing Targeted RNA Degradation in Antiviral Discovery,” has been selected for NIH/NIAID R21 funding.

January 28, 2026

We are grateful to share that our project, “Development of RNA Splicing Modulators for the Treatment of Creutzfeldt–Jakob Disease (CJD),” has been selected for a CJD Foundation grant. We thank the CJD Foundation and the donor families for making this work possible. 

©2019 Wang Lab

  • Twitter
  • Google Places
  • LinkedIn
bottom of page